[Diagnosis and therapy for Sjogren syndrome].
Sumida
Takayuki
T
D000974:Antibodies, Antinuclear / Q000097:blood; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D015551:Autoimmunity; D015415:Biomarkers / Q000097:blood; D003937:Diagnosis, Differential; D005938:Glucocorticoids / Q000008:administration & dosage; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D011239:Prednisolone / Q000008:administration & dosage; D012015:Reference Standards; D012017:Referral and Consultation; D012859:Sjogren's Syndrome / Q000175:diagnosis* / Q000276:immunology / Q000503:physiopathology / Q000628:therapy*; D014409:Tumor Necrosis Factor-alpha / Q000276:immunology
D000974:Antibodies, Antinuclear; D000911:Antibodies, Monoclonal; D015415:Biomarkers; D005938:Glucocorticoids; D007166:Immunosuppressive Agents; C035356:SS-A antibodies; C035357:SS-B antibodies; D014409:Tumor Necrosis Factor-alpha; D011239:Prednisolone